Moleculaire afwijkingen en doelgerichte therapieën in blaaskanker
Crossref DOI link: https://doi.org/10.1007/s13629-026-00488-6
Published Online: 2026-02-09
Published Print: 2026-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Olislagers, Mitchell https://orcid.org/0000-0002-4002-9006
Zuiverloon, Tahlita C. M. https://orcid.org/0000-0003-0991-0812
Text and Data Mining valid from 2026-02-09
Version of Record valid from 2026-02-09
Article History
Accepted: 14 January 2026
First Online: 9 February 2026